Favourable Results of Patritumab Deruxtecan in Patients with Leptomeningeal Metastatic Disease of Solid Tumours By Ogkologos - July 21, 2025 364 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the TUXEDO-3 study Source RELATED ARTICLESMORE FROM AUTHOR New Targeted Therapy Shows Promising Early Results in Advanced Pancreatic Cancer FDA Approves Pivekimab Sunirine-pvzy for Blastic Plasmacytoid Dendritic Cell Neoplasm, an Ultra-Rare Haematologic Malignancy Ivonescimab Plus Chemotherapy Improves OS Compared with Tislelizumab Plus Chemotherapy in Previously Untreated Patients with Advanced Squamous NSCLC MOST POPULAR Measurable Residual Disease Adapted Consolidation Strategy After Quadruplet Induction Therapy for... July 8, 2025 Black Patients Are More Likely to Die of Cancer—Here’s How One... December 21, 2021 Combining Niraparib with Abiraterone Acetate and Prednisone Significantly Improves rPFS in... October 22, 2025 When Natural Disasters Strike, This Program Helps Provide Relief To People... October 3, 2019 Load more HOT NEWS Presence of Intratumoural TLSs in Advanced STS as a Potential Predictive... Molecular Profiling Identifies Targetable Alterations in Majority of Patients with Advanced... Dog Showers His Mom with Snuggles and Makes Her Laugh During... Doctor Wipes Away The Debt Of 200 Cancer Patients
